Develops research, programs, and initiatives designed to envision and activate sustainable solutions leading to better health for individuals and communities worldwide.
While COVID-19 and recent natural disasters have demonstrated the fundamental resilience of the glob
al pharmaceutical supply chain, they have also revealed blind spots, such as growing health inequities, that threaten our ability to advance broader publ,
Responding to supply chain challenges requires adaptation and coordination.
, Addressing Health Equity Challenges and Opportunities
COVID-19 has reinforced that large-scale public health challenges can further dr